The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kramer Robin since 2017.
This trader's CIK number is 1609222.
At the time of last reporting, Kramer Robin was the Chief Accounting Officer of Biogen Inc.. (stock ticker symbol BIIB).
Also see all insider trading activities at Biogen Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | HTZ | 0 | $0 | 5,450 | $107,201 | 15,301 | $0 |
2017 | HTZ | 0 | $0 | 3,524 | $75,882 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | BIIB | 0 | $0 | 0 | $0 | 1,491 | $0 |
2024 | BIIB | 0 | $0 | 0 | $0 | 2,966 | $0 |
2023 | BIIB | 0 | $0 | 0 | $0 | 2,176 | $0 |
2022 | BIIB | 0 | $0 | 0 | $0 | 1,273 | $0 |
2021 | BIIB | 0 | $0 | 0 | $0 | 923 | $163,486 |
2020 | BIIB | 0 | $0 | 0 | $0 | 206 | $0 |
2019 | BIIB | 0 | $0 | 0 | $0 | 84 | $0 |
1. Hertz Global Holdings, Inc (HTZ)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-04-29 | HTZ | Option Ex | 798 | .00 | 0 |
2018-03-08 | HTZ | Sale | 5,450 | 19.67 | 107,201 |
2018-03-02 | HTZ | Option Ex | 14,503 | .00 | 0 |
2017-09-14 | HTZ | Sale | 3,524 | 21.53 | 75,882 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-02-07 | BIIB | Option Ex | 1,491 | .00 | 0 |
2024-02-16 | BIIB | Option Ex | 1,345 | .00 | 0 |
2024-02-09 | BIIB | Option Ex | 833 | .00 | 0 |
2024-02-08 | BIIB | Option Ex | 788 | .00 | 0 |
2023-12-08 | BIIB | Option Ex | 351 | .00 | 0 |
2023-06-30 | BIIB | Option Ex | 252 | .00 | 0 |
2023-02-17 | BIIB | Option Ex | 512 | .00 | 0 |
2023-02-10 | BIIB | Option Ex | 1,061 | .00 | 0 |
2022-12-08 | BIIB | Option Ex | 350 | .00 | 0 |
2022-07-01 | BIIB | Option Ex | 252 | .00 | 0 |
2022-02-18 | BIIB | Option Ex | 396 | .00 | 0 |
2022-02-12 | BIIB | Option Ex | 275 | .00 | 0 |
2021-12-03 | BIIB | Option Ex | 339 | 223.92 | 75,908 |
2021-07-01 | BIIB | Option Ex | 251 | 348.92 | 87,578 |
2021-02-12 | BIIB | Option Ex | 333 | .00 | 0 |
2020-12-03 | BIIB | Option Ex | 74 | .00 | 0 |
2020-02-12 | BIIB | Option Ex | 132 | .00 | 0 |
2019-12-03 | BIIB | Option Ex | 84 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kramer Robin (Chief Accounting Officer of Biogen Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.